InvestorsHub Logo
Followers 618
Posts 37928
Boards Moderated 9
Alias Born 08/15/2009

Re: JoJr post# 14642

Monday, 02/06/2023 11:36:37 AM

Monday, February 06, 2023 11:36:37 AM

Post# of 14793
With positive clinical trials it could become a $Billion dollar market cap fast.

But like I said, it will get gobbled up by Big Pharma before they allow that.
The best case scenario Is the stock remains public and we get a marketing partnership with Big Pharma.

The way these play out. FDA approval gets the mother of all runs. Then massive MM short, because it must then shown to actually sell. Then a buy out or marketing PR sends it into the stratosphere.

MITI, Micromet was a straight up buy out of all stock on potential. $3 to $14 over night. I’m still in a class action over the CEO selling out to low.
VMRLQ, Vernillion was an FDA approval. .05 to $5, then shorted below $2.50. Quest came out a week later with a marketing partnership snd it ran above $15. I’m still using those gains today playing these penny stocks.

This Alzheimer’s sector is Mega money. I can see a $B market cap easy. If it works and doesn’t kill everyone.